APA aipamena

Ladanyi, M., Sanchez Vega, F., & Zauderer, M. (2019). Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma. Genome Med.

Chicago Style aipamena

Ladanyi, Marc, Francisco Sanchez Vega, and Marjorie Zauderer. "Loss of BAP1 As a Candidate Predictive Biomarker for Immunotherapy of Mesothelioma." Genome Med 2019.

MLA aipamena

Ladanyi, Marc, Francisco Sanchez Vega, and Marjorie Zauderer. "Loss of BAP1 As a Candidate Predictive Biomarker for Immunotherapy of Mesothelioma." Genome Med 2019.